Lenvima (lenvatinib) is a kinase inhibitor used to treat certain types of cancer. Kinase inhibitors are enzyme inhibitors that blocks the action of one or more protein kinases which interferes with the growth and spread of cancer cells in the body.
Lenvima is used to treat thyroid cancer. It is usually given after radioactive iodine has been tried without success.
Lenvima is used together with everolimus (Afinitor) to treat advanced kidney cancer when other medicines have not been effective.
Lenvima is used together with pembrolizumab (Keytruda) to treat a certain type of endometrial cancer (a type of uterine cancer) that has progressed and cannot be removed with surgery or radiation.
Lenvima is also used to treat liver cancer that cannot be removed with surgery.
